Bioinformatics analysis reveals TSPAN1 as a candidate biomarker of progression and prognosis in pancreatic cancer

Pancreatic cancer (PCC) is a common malignant tumor of the digestive system that is resistant to traditional treatments and has an overall 5-year survival rate of <7%. Transcriptomics research provides reliable biomarkers for diagnosis, prognosis, and clinical precision treatment, as well as the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Chenhui, Cui, ZeLong, Wang, YiChao, Zhang, Lei, Wen, JunYe, Guo, HuaiBin, Li, Na, Zhang, WanXing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861625/
https://www.ncbi.nlm.nih.gov/pubmed/33188589
http://dx.doi.org/10.17305/bjbms.2020.5096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861625/
https://www.ncbi.nlm.nih.gov/pubmed/33188589
http://dx.doi.org/10.17305/bjbms.2020.5096

Ejemplares similares